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Abstract 
Hemoglobin A1c (HbA1c) has an N-terminal fructosyl valine on the β-chain, and this modification is caused by the 
non-enzymatic glycosylation of hemoglobin (Hb). The relative concentration ratio of HbA1c to total Hb is an important 
biomarker for the diagnosis of diabetes. HbA1c-binding lectins were screened from 29 sources of lectin, and the lectin 
from Aleuria aurantia (AAL) was revealed to have higher affinity to HbA1c than to Hb. The concentration of HbA1c was 
determined by lectin-based enzyme-linked immunosorbent assay (ELISA) using the AAL lectin. Higher reproducibility 
of the assay was observed at 4 °C than at 25 and 37 °C. This observation is consistent with the known temperature-
dependent behavior of lectins. Preincubation of HbA1c with an anti-HbA1c antibody inhibited the binding, suggesting 
that AAL binds to the N-terminal fructosyl valine epitope of HbA1c. Higher inhibitory effect was observed for 10 mM 
d-fructose than for the same concentrations of l-fucose, d-fucose, or d-glucose.
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Introduction
The number of people with diabetes is increasing glob-
ally, especially in developing countries, with over 346 
million people diagnosed worldwide (Little and Rohlf-
ing 2013). The major hallmark of diabetes is high glu-
cose levels in the blood. However, the concentration of 
glucose in the blood is not reliable for the diagnosis of 
diabetes because of fluctuations in these concentrations 
throughout the day. The relative concentration ratio of 
hemoglobin A1c (HbA1c) to hemoglobin (Hb) is a reli-
able biomarker for the diagnosis and prognosis of dia-
betes (Little and Rohlfing 2013). HbA1c is produced by 
a non-enzymatic reaction between glucose (McDonald 
et al. 1978) and the N-terminal valine of the β-chain of 
hemoglobin in red blood cells. The reaction proceeds 
via a Schiff base adduct, followed by the Amadori rear-
rangement to form a stable fructosyl valine, which exists 
almost exclusively in the pyranose form (Mortensen and 
Christophersen 1982). Since the half-life of red blood 
cells is approximately 2  months, the concentration of 
HbA1c represents the blood glucose levels over the 
past 2–3  months. Since the first quantitative assay of 
HbA1c (Trivelli et  al. 1971), the assay method has been 
improved by a rapid automated assay (Klenk et al. 1982) 
and an automated immunoassay (Fiore et al. 1988), and 
the enzymatic assay using fructosyl amino acid oxidase 
(Sakurabayashi et  al. 2003). Conventional HbA1c assay 
methods available to clinical laboratories are based on 
the chromatographic method (Imagawa et  al. 1984), 
the latex-enhanced immunoturbidimetric method 
(Holownia et  al. 1997), or the enzymatic method using 
fructosyl-valine oxidase (Hirokawa et  al. 2004). The 
chromatographic method, involving the use of HPLC for 
the separation of HbA1c and Hb, is rather expensive. The 
latex-enhanced immunoturbidimetric method monitors 
increase in solution turbidity, which is caused by the 
interactions between HbA1c and the antibodies against 
fructosyl-valine of HbA1c that are coated on the sur-
face of latex beads. In this method, HbA1c is denatured 
before the assay so that the N-terminal fructosyl valine is 
exposed (Holownia et al. 1997). The enzymatic method 
uses fructosyl-valine oxidase for oxidation of the gly-
cated N-terminal amino group of the partially digested 
HbA1c to produce hydrogen peroxide, which is subse-
quently used for color development.
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Lectins are carbohydrate-binding proteins produced 
by many organisms including fungi, animals, plants, and 
bacteria. Binding affinity of some lectins to glycoprotein 
increases at lower temperatures (Hayes and Goldstein 
1975; Ebisu et al. 1978; Damian et al. 2005). It is hypoth-
esized that water molecules contribute to the binding 
between sugar and lectin, and tend to be displaced at 
higher temperatures (Damian et  al. 2005). Fungal lectin 
from Aleuria aurantia (AAL) is a fucose binding lec-
tin, and the binding is inhibited by l-fucose, but not by 
d-fucose. AAL differs from other fucose-binding lectins 
by having a broad affinity towards l-fucose-containing 
saccharides (Olausson et al. 2008). AAL can be used for 
the assay of serum fucosylated haptoglobin for diagno-
sis of hepatocellular carcinoma (Kondo et al. 1995). AAL 
also binds to d-arabinose, which lacks the C-6 methyl 
group of l-fucose (Fukumori et  al. 1990), although the 
binding affinity to it is 30 times weaker than that to 
l-fucose (Fujihashi et al. 2003). Recombinant AAL can be 
overproduced in Escherichia coli (Fukumori et al. 1990), 
and the overproduced AAL is stable after incubation at 
55 °C for 10 min (Amano et al. 2003). AAL is composed 
of two identical subunits of approximately 33  kDa, and 
each subunit has its sixfold β-propeller structure with 
five l-fucose-binding sites to bind to the α- or β-anomer 
form of l-fucose (Fujihashi et al. 2003; Wimmerova et al. 
2003).
This study revealed an interaction between AAL and 
HbA1c using a lectin-based ELISA method. This finding 
can be applied to develop an HbA1c assay for the diagno-
sis of diabetes. AAL offers several advantages for use in 
an HbA1c assay, such as its thermostability and the lower 
cost of production than that of antibody- or enzyme-
based assays, which are the currently used methods.
Materials and methods
Materials
All biotinylated lectins described in this report were 
obtained from J-oil Mills, Inc., Tokyo, Japan. ELISA 
plates (half area 96 well, flat bottom) were purchased 
from Greiner Bio-One, Frickenhausen, Germany. Human 
hemoglobin was obtained from Sigma-Aldrich (St. 
Louis, MO, USA). Highly purified HbA1c was purchased 
from BBI Solutions (Cardiff, UK). Monoclonal antibody 
against HbA1c was purchased from Abnova Corp. (Tai-
pei, Taiwan). Bovine serum albumin for the blocking of 
the plates was purchased from Jackson Immuno Research 
Laboratories (West Grove, PA, USA). All the other rea-
gents were purchased from Wako Pure Chemical Indus-
tries (Osaka, Japan), unless otherwise stated.
Lectin‑based ELISA
Interactions between AAL and Hb or HbA1c were 
assayed by lectin-based ELISA. Hb or HbA1c was dena-
tured by incubation in 1.0 M acetate buffer (pH 5.0) for 
30 min at 25  °C. A volume of 25 μl of denatured Hb or 
HbA1c (150  μg/ml) was added to the ELISA plate, and 
each well was washed with PBS-T, consisting of PBS 
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM 
KH2PO4) and 0.05  % Tween 20, and then blocked by 
the addition of 1 mg/ml BSA in PBS at 37 °C for 60 min. 
After washing with PBS-T, the plate was incubated with 
25 μl of biotinylated lectin (5 μg/ml) in PBS with 1 mg/
ml BSA for 1  h. Biotin labeled-lectins from Aleuria 
aurantia (AAL), Agaricus bisporus (ABA), Amaranthus 
caudatus (ACA), Agrocybe cylindracea (ACG), Arachis 
hypogaea (PNA), Bauhinia purpurea (BPA), Canavalia 
ensiformis (ConA), Canavalia gladiata (CGA), Gal-
anthus elwesii (GEA), Glycine max (SBA), Dolichos 
biflorus (DBA), Datura stramonium (DSA), Erythrina 
cristagalli (ECA), Galanthus elwesii (GEA), Hippeat-
rum hybrid (HHA), Hygrophorus russula (HRL), Lens 
culinaris (LCA), Lotus tetragonolobus (Lotus), Maackia 
amurensis (MAM), Maclura pomifera (MPA), Phaseo-
lus vulgaris (PHA-E4 and PHA-L4), Pholiota squarrosa 
(PhoSL), Psophocarpus tetragonolobus (PTA-I), Ricinus 
communis (RCA120), Sambucus sieboldiana (SSA), Trit-
icum vulgaris (WGA), Tulipa gesneriana (TxLc-I), Ulex 
europaeus (UEA-I), and Vicia villosa (VVA-G) were 
screened. After washing with PBS-T, 25 μl of high sen-
sitivity streptavidin-HRP (1 μg/ml, Thermo Fisher Scien-
tific, Waltham, MA, USA) in PBS with 1 mg/ml BSA was 
added and incubated for 1  h. After washing with PBS-
T, color was developed with TMB peroxidase substrate 
system (KPL, Gaithersburg, MD, USA) according to the 
manufacturer’s instructions.
After the screening experiment, the subsequent experi-
ments were further optimized. The denatured Hb or 
HbA1c was neutralized by the addition of more than 
ten times the initial volume of 0.1  M sodium carbon-
ate buffer (pH 9.5) for the efficient binding to the ELISA 
plate. Furthermore, the plates were kept at 4 °C after the 
addition of biotinylated AAL for the reproducibility. The 
inhibitory effect of the anti-HbA1c antibody (10  μg/ml) 
was determined by adding it to the neutralized HbA1c 
after denaturation. For the assay of the inhibitory effect 
of sugars, biotinylated AAL was incubated with 10  mM 
l-fucose, d-fucose, d-fructose, or d-glucose before its 
addition to the plate. All data are shown as the mean 
value of at least three measurements with error bars of 
one standard deviation.
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Results
Screening of HbA1c‑binding lectins
HbA1c-binding lectins were screened from 30 sources 
using lectin-based ELISA, as described in the “Materi-
als and methods” section. Among the screened lectins, 
eight (AAL, DBA, ECA, HHA, LCA, Lotus, MPA, and 
UEA-I) were found to bind to HbA1c, although they 
showed similar or higher binding-affinity to Hb except 
for AAL (Fig.  1). AAL was selected for further experi-
ments as it was found to bind with HbA1c, but not with 
Hb. The binding Fig. 2 shows the binding between AAL 
and HbA1c and between AAL and Hb. The results show 
that AAL binding increased as the HbA1c concentration 
increased. However, only a small increase in binding 
was observed when the Hb concentration increased. The 
neutralization before the addition of the ELISA plates 
increased the values of ELISA, because high pH buffer 
can increase the solubility of the proteins and makes the 
proteins unprotonated which helps binding to a posi-
tively charged ELISA plates.
Effect of temperature
Binding affinities between lectins and saccharides are 
often enhanced at lower temperatures. The effect of tem-
perature on the lectin-based ELISA was determined by 
decreasing the solution temperature after the addition 
of biotinylated AAL as described in the “Materials and 
methods” section. Although the solution temperature has 
a slight effect on the average values of binding to HbA1c 
(data not shown), higher reproducibility was observed 
at lower temperatures. The average of coefficient of 
validation for the values of HbA1c binding, as shown in 
Fig. 2, was 0.049. However, this average value at 25 and 
37 °C, increased to 0.080 and 0.11, respectively (data not 
shown).
Inhibitory effect of the anti‑HbA1c antibody
The inhibitory effect of the monoclonal antibody against 
the N-terminal fructosyl valine of β-chain of HbA1c on 
the binding between AAL and HbA1c was assayed in 
order to obtain information about the binding position 
of HbA1c. The antibody was incubated with denatured 
HbA1c and lectin-based ELISA was performed. Figure 3 
shows the effect of the antibody on the binding. The 
binding was inhibited by the incubation of the antibody 
and HbA1c prior to the lectin-based ELISA. This result 
suggests that AAL binds to the N-terminal fructosyl 
valine of the β-chain of HbA1c.
l-Fucose occupies the binding sites of AAL and inhibits 
the binding of AAL to l-fucose-containing glycans. The 
binding sites of AAL to HbA1c were assumed by deter-
mining the inhibition effects of various sugars. Table  1 
shows the effect of 10 mM l-fucose, d-fucose, d-fructose, 
d-glucose, and d-arabinose on the interaction between 
AAL and HbA1c. The inhibition by d-fructose was higher 
than that by the other sugars, including l-fucose. These 
results suggest that AAL binds to the N-terminal fructo-
syl valine at a binding site distinct from that of l-fucose.
Discussion
This report revealed that AAL binds to HbA1c, which 
is a glucose modified Hb. This is the first report show-
ing interaction between HbA1c and AAL, which has 
been shown to interact with saccharides contain-
ing l-fucose or d-arabinose. The results of the lec-




































Fig. 1 Screening of hemoglobin A1c-binding lectins. The denatured hemoglobin A1c (white) or hemoglobin (black) was immobilized on the surface 
of the plate before the neutralization. The binding of biotinylated lectins was assayed by the activity of the specifically bound streptavidin-HRP
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binding affinity with HbA1c than that with Hb. Since 
the modification by glucose differentiates HbA1c from 
Hb, AAL is suggested to bind to fructosyl valine of the 
β-chain of HbA1c. This hypothesis is consistent with 
the observed inhibitory effect of the antibody against 
fructosyl valine (Fig.  3). This binding is explained by 
the broad binding affinity of lectin. AAL also binds 
to d-arabinose, which lacks the C-6 methyl group 
of l-fucose, although the binding affinity is 30 times 
weaker than that to l-fucose (Fujihashi et  al. 2003). 
Figure  4 compares the structural formulas of the 
hypothetical ligand d-fructosyl valine and its known 
ligands l-fucose and d-arabinose. Three of these pyra-
noses share the same configuration of all four hydroxyl 
groups at chiral carbons (C-1, C-2, C-3, and C-4). It 
is possible that AAL binds to the fructosyl valine of 
β-chain of HbA1c, as does l-fucose-containing saccha-
rides. However, the binding may be partially distinct 
from each other, which could result in the distinct 
inhibition in the presence of l-fucose or l-fructose.
The reproducibility increased at 4 °C as compared to 25 
and 37  °C. These results are likely caused by the higher 
binding affinity at lower temperatures. Higher affinity at 
lower temperature is often reported in the interactions 
between lectins and saccharides. Damian et  al. (2005) 
suggested that the higher affinity at lower temperatures 
is caused by stabilization of water molecules that con-
tribute to the binding. The interaction between AAL and 
HbA1c may require water molecules.
AAL could be used for the assay of HbA1c in human 
blood for the diagnosis of diabetes. Since AAL can be 
overproduced in E. coli and shows higher thermostability, 
a diagnostic test using AAL may be superior to the con-
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Fig. 2 Binding between the lectin from Aleuria aurantia (AAL) and 
HbA1c or Hb. The denatured HbA1c (filled circle) or Hb (open square) 
were immobilized on the surface of the plate and the amount of 
biotinylated AAL bound to the protein was assayed by the activity of 
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Fig. 3 Inhibition of the binding by the monoclonal antibody against 
HbA1c. The lectin-based ELISA was performed in the presence (open 
triangle) and the absence (closed circle) of the anti-HbA1c monoclonal 
antibody (10 μg/ml)
Table 1 Inhibitory effect of sugars on the values of the lec-
tin-based ELISA
a The values of the lectin-based ELISA for 0.15 μg HbA1c in the presence and the 









Fig. 4 Comparison of structural formulas of fructosyl valine and the 
known ligands of AAL
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